Gilead Sciences Inc
GILD.MX
| Exchange: | MX |
| Currency | Mexican Peso |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Drug Manufacturers - General |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Pharmaceuticals |
| Gic Sub Industry: | Pharmaceuticals |
| Description: | Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and Am Bisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California. |
| Address: | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
| Website: | https://www.gilead.com |
| Full Time Employees: | 18000 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 2279458996224 |
| Market Capitalization Mln: | 2279458.99 |
| EBITDA: | 13461999616 |
| PE Ratio: | 110.77 |
| PEG Ratio: | 0.51 |
| Book Value: | 14.67 |
| Dividend Share: | 3.04 |
| Dividend Yield: | 0.03 |
| Earnings Share: | 16.43 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.03 |
| Operating Margin TTM: | 0.38 |
| Return On Assets TTM: | 0.11 |
| Return On Equity TTM: | 0.05 |
| Revenue TTM: | 27804999680 |
| Revenue Per Share TTM: | 22.29 |
| Quarterly Revenue Growth YOY: | 0.05 |
| Gross Profit TTM: | 21624000000 |
| Diluted Eps TTM: | 16.43 |
| Quarterly Earnings Growth YOY: | 0.55 |
Valuation
| Trailing PE: | 110.77 |
| Forward PE: | 12.15 |
| Price Sales TTM: | 81.98 |
| Price Book MRQ: | 6.05 |
| Enterprise Value: | 2649467214764 |
| Enterprise Value Revenue: | 4.74 |
| Enterprise Value Ebitda: | 25.05 |
Shares
| Shares Outstanding: | 1244989952 |
| Shares Float: | 1242589246 |
| Percent Insiders: | 0.11 |
| Percent Institutions: | 87.96 |
Technicals
| Beta: | 0.19 |
| 52 Week High: | 1820 |
| 52 Week Low: | 1024.42 |
| 50 Day MA: | 1598.16 |
| 200 Day MA: | 1322.66 |
Splits & Dividends
| Forward Annual Dividend Rate: | 60.46 |
| Forward Annual Dividend Yield: | 0.03 |
| Payout Ratio: | 3.70 |
| Ex Dividend Date: | 2024-09-13 |
| Last Split Factor: | 2:1 |
| Last Split Date: | 2013-01-28 |
Earnings
| Report Date: | 2025-05-08 |
| Date: | 2025-03-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Report Date: | 2025-02-04 |
| Date: | 2024-12-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Report Date: | 2024-11-06 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | MXN |
| Report Date: | 2024-08-08 |
| Date: | 2024-06-30 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 22.25 |
| Report Date: | 2024-04-25 |
| Date: | 2024-03-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | -56.82 |
| Report Date: | 2024-03-13 |
| Date: | 2023-12-31 |
| Before After Market: | Before Market |
| Currency: | MXN |
| Eps Actual: | 19.98 |
| Report Date: | 2023-10-17 |
| Date: | 2023-09-30 |
| Before After Market: | Before Market |
| Currency: | MXN |
| Eps Actual: | 29.59 |
| Report Date: | 2023-08-03 |
| Date: | 2023-06-30 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 14.69 |
| Report Date: | 2023-04-27 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 14.94 |
| Report Date: | 2023-02-02 |
| Date: | 2022-12-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 25.53 |
| Report Date: | 2022-10-27 |
| Date: | 2022-09-30 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 28.72 |
| Report Date: | 2022-08-02 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 18.21 |
| Report Date: | 2022-04-28 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 0.30 |
| Report Date: | 2022-02-01 |
| Date: | 2021-12-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 6.28 |
| Report Date: | 2021-10-28 |
| Date: | 2021-09-30 |
| Currency: | MXN |
| Eps Actual: | 41.14 |
| Report Date: | 2021-07-29 |
| Date: | 2021-06-30 |
| Currency: | MXN |
| Eps Actual: | 24.16 |
| Report Date: | 2021-04-29 |
| Date: | 2021-03-31 |
| Currency: | MXN |
| Eps Actual: | 27.88 |
| Report Date: | 2021-02-04 |
| Date: | 2020-12-31 |
| Currency: | MXN |
| Eps Actual: | 25.32 |
| Report Date: | 2020-09-30 |
| Date: | 2020-09-30 |
| Currency: | MXN |
| Eps Actual: | 6.30 |
| Report Date: | 2020-06-30 |
| Date: | 2020-06-30 |
| Currency: | MXN |
| Eps Actual: | -62.02 |
| Report Date: | 2020-03-31 |
| Date: | 2020-03-31 |
| Currency: | MXN |
| Eps Actual: | 24.48 |
| Report Date: | 2019-12-31 |
| Date: | 2019-12-31 |
| Currency: | MXN |
| Eps Actual: | 40.77 |
| Report Date: | 2019-09-30 |
| Date: | 2019-09-30 |
| Currency: | MXN |
| Eps Actual: | -17.86 |
| Report Date: | 2019-06-30 |
| Date: | 2019-06-30 |
| Currency: | MXN |
| Eps Actual: | 28.14 |
| Report Date: | 2019-03-31 |
| Date: | 2019-03-31 |
| Currency: | MXN |
| Eps Actual: | 29.55 |
| Report Date: | 2018-12-31 |
| Date: | 2018-12-31 |
| Currency: | MXN |
| Eps Actual: | 0.04 |
| Report Date: | 2018-09-30 |
| Date: | 2018-09-30 |
| Currency: | MXN |
| Eps Actual: | 30.41 |
| Report Date: | 2018-06-30 |
| Date: | 2018-06-30 |
| Currency: | MXN |
| Eps Actual: | 26.98 |
| Report Date: | 2018-03-31 |
| Date: | 2018-03-31 |
| Currency: | MXN |
| Eps Actual: | 21.82 |
| Report Date: | 2017-12-31 |
| Date: | 2017-12-31 |
| Currency: | MXN |
| Eps Actual: | -56.09 |
| Report Date: | 2017-09-30 |
| Date: | 2017-09-30 |
| Currency: | MXN |
| Eps Actual: | 36.73 |
| Report Date: | 2017-06-30 |
| Date: | 2017-06-30 |
| Currency: | MXN |
| Eps Actual: | 43.26 |
| Report Date: | 2017-03-31 |
| Date: | 2017-03-31 |
| Currency: | MXN |
| Eps Actual: | 41.55 |
| Report Date: | 2016-12-31 |
| Date: | 2016-12-31 |
| Currency: | MXN |
| Eps Actual: | 46.48 |
| Report Date: | 2016-09-30 |
| Date: | 2016-09-30 |
| Currency: | MXN |
| Eps Actual: | 46.65 |
| Report Date: | 2016-06-30 |
| Date: | 2016-06-30 |
| Currency: | MXN |
| Eps Actual: | 46.73 |
| Report Date: | 2016-03-31 |
| Date: | 2016-03-31 |
| Currency: | MXN |
| Eps Actual: | 45.58 |
| Report Date: | 2015-12-31 |
| Date: | 2015-12-31 |
| Currency: | MXN |
| Eps Actual: | 53.3 |
| Report Date: | 2015-09-30 |
| Date: | 2015-09-30 |
| Currency: | MXN |
| Eps Actual: | 50.28 |
| Date: | 2024-09-30 |
| Eps Actual: | -34.56 |
| Date: | 2023-12-31 |
| Eps Actual: | 79.21 |
| Date: | 2022-12-31 |
| Eps Actual: | 72.77 |
| Date: | 2021-12-31 |
| Eps Actual: | 99.48 |
| Date: | 2020-12-31 |
| Eps Actual: | -5.91 |
| Date: | 2019-12-31 |
| Eps Actual: | 80.61 |
| Date: | 2018-12-31 |
| Eps Actual: | 79.26 |
| Date: | 2017-12-31 |
| Eps Actual: | 65.46 |
| Date: | 2016-12-31 |
| Eps Actual: | 185.46 |
| Date: | 2015-12-31 |
| Eps Actual: | 103.58 |